Association of GLP-1 Receptor Agonists with COPD Exacerbations Among Patients with Type 2 Diabetes.
Dinah FoerZachary H StrasserJing CuiKatherine N CahillJoshua A BoyceShawn N MurphyElizabeth W KarlsonPublished in: American journal of respiratory and critical care medicine (2023)
Prospective studies of COPD exacerbations in patients with comorbid T2D are warranted. Additional study may elucidate mechanisms underlying observed associations with T2D medications.